🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for hereditary breast carcinoma

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 NCT07292168Phase 1, Phase 25 sites📍 Kazan'📍 Krasnoyarsk📍 Moscow Kidney Cancer Research Bureau · Tests: humanized monoclonal anti-FGFR1 antibody OM-RCA-01 A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites📍 New York📍 Huntersville📍 San Antonio Arvinas Inc. · Tests: ARV-6723, Pembrolizumab, SOC Increasing Germline Genetic Testing for Patients With Cancer NCT07307664NA10 sites📍 Los Angeles📍 Orlando📍 Decatur Josh Peterson · Tests: Implementation strategies InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2 NCT05835739n/a12 sites📍 Aviano📍 Genova📍 Messina Centro di Riferimento Oncologico - Aviano EHR Intervention to Increase HBOC Genetic Testing NCT07876349NA1 site📍 New York Columbia University · Tests: ELISABETH Evidence-Informed Program (EIP) Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics NCT05694559NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Genetic Testing and Counseling, Screening Form InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples Sapu003 in Advanced mTOR-sensitive Solid Tumors NCT07369505Phase 11 site📍 Adelaide SAPU NANO (US) LLC · Tests: Sapu003, Exemestane 25 MG Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital CfDNA in Hereditary And High-risk Malignancies 2 NCT06726642n/a8 sites📍 Vancouver📍 St. John's📍 Halifax University Health Network, Toronto · Tests: Cell-free DNA analysis CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing NCT05130606NA2 sites📍 Washington D.C.📍 Richmond Georgetown University · Tests: Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor.", FORCE Fact … Identifying and Caring for Individuals With Inherited Cancer Syndrome NCT04494945NA2 sites📍 Portland📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Genetic Counseling, Genetic Testing, Survey Administration First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors NCT05768139Phase 1, Phase 265 sites📍 Los Angeles📍 San Francisco📍 Aurora Eli Lilly and Company · Tests: STX-478, Fulvestrant, Ribociclib, Palbociclib, Letrozole Population Based Germline Testing for Early Detection and Prevention of Cancer NCT07498829NA1 site📍 London Queen Mary University of London · Tests: Genetic testing for Cancer Susceptibility Genes (CSGs) (BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2, MLH1, MSH2, MSH6) a… The Cancer of the Pancreas Screening-5 CAPS5)Study NCT02000089Phase 39 sites📍 New Haven📍 Baltimore📍 Boston Johns Hopkins University · Tests: Secretin, MRI, Tumor marker gene test with CA19-9 A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer NCT05683418Phase 118 sites📍 Chicago📍 Boston📍 Boston Totus Medicines · Tests: TOS-358, Fulvestrant, Palbociclib, Ribociclib A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors NCT07540572Phase 111 sites📍 Plantation📍 East Brunswick📍 Lake Success IDEAYA Biosciences · Tests: IDE574, Fulvestrant injection ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health NCT07505797n/a2 sites📍 Sacramento📍 Cypress iSono Health, Inc. · Tests: ATUSA 3D Automated Breast Ultrasound System Specimen and Data Study for Ovarian Cancer Early Detection and Prevention NCT00005095n/a1 site📍 Chicago Northwestern University · Tests: Ca-125, screening questionnaire administration, Surgery Pancreatic Cancer Genetics NCT01102569n/a1 site📍 New York Columbia University A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer NCT07532434n/a1 site📍 Beijing Peking University Third Hospital Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer NCT06888388n/a16 sites📍 New Haven📍 Boston📍 New York Sir Mortimer B. Davis - Jewish General Hospital · Tests: Nipple Sparing Mastectomy (NSM), Skin-Sparing Mastectomy (SSM), Total (Simple) Mastectomy Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer NCT07558733Phase 1, Phase 27 sites📍 Los Angeles📍 Lone Tree📍 Springfield Faeth Therapeutics · Tests: Serabelisib, Sapanisertib, Fulvestrant Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors NCT06993844Phase 1, Phase 215 sites📍 Newport Beach📍 San Francisco📍 New Haven Ensem Therapeutics · Tests: ETX-636 dose escalation, ETX-636 dose escalation in combination with fulvestrant, ETX-636 dose expansion in combination… Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland NCT03124212n/a9 sites📍 Fribourg📍 Geneva📍 Delémont University of Basel · Tests: CASCADE genetic screening The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI NCT06892275NA1 site📍 Washington D.C. Georgetown University · Tests: Enhanced Usual Care, Decision Support CTNNA1 Familial Expansion Study NCT05126290n/a1 site📍 Philadelphia Abramson Cancer Center at Penn Medicine · Tests: Collection of personal and family history from CAFÉ Study participants Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer NCT06365788Phase 26 sites📍 Antwerp📍 Antwerp📍 Brussels Universitaire Ziekenhuizen KU Leuven · Tests: Abemaciclib, Bicalutamide
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy